Abstract:Phloretin is a natural dihydrochalcone flavonoid that is mainly distributed in apple, pear and other juicy fruit peels or root peels. Phloretin exhibits several pharmacological properties, such as antidiabetic, antioxidant, anti-inflammatory, and antitumor activities. However, the poor water solubility of phloretin limits its application in the treatment of numerous diseases. To date, the underlying mechanisms of phloretin absorption have not been investigated. In this study, the pharmacokinetics of phloretin orally administered to Sprague-Dawley (SD) rats were examined, and the absorption mechanisms of phloretin were investigated in a Caco-2 cell monolayer and single-pass intestinal perfusion in SD rat. The effects measured by basic parameters, such as compound concentration, time, temperature, paracellular pathway, in different intestinal segments were analyzed, and various inhibitors, such as the P-glycoprotein (P-gp) inhibitor verapamil, the multidrug resistance protein 2 (MRP2) inhibitor indomethacin, the breast cancer resistance protein (BCRP) inhibitor reserpine, and the closely related regulator EDTA, were evaluated to determine their effects on the absorption of phloretin. The pharmacokinetics of phloretin was studied by oral and intravenous injection in rats. The bioavailability was 8.676 %.The SPIP experiments showed that P-gp, MRP2, BCRP protein inhibitor and closely related regulator, could significantly increase the apparent permeability coefficient (Papp) of phloretin. Monolayer transport experiments in Caco-2 cells showed that P-gp, MRP2 protein inhibitor and closely related regulator EDTA, significantly increased the Papp value of phloretin. In conclusion, phloretin is a substrate of P-gp and MRP2, and its modes of transport include active transport, efflux protein transport and cell bypass.

Health effects of phloretin: from chemistry to medicine

Dermatological applications of the flavonoid phloretin

Phloretin: a comprehensive review of its potential against diabetes and associated complications

The Bioavailability, Extraction, Biosynthesis and Distribution of Natural Dihydrochalcone: Phloridzin

Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro

Synthesis, crystal structure, and biological evaluation of a series of phloretin derivatives

Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives

Protective Effects of Chrysin Against Drugs and Toxic Agents

Therapeutic indication of Phloridzin: A new Gleam for metabolic disorders

In Silico Comparison of Quantum and Bioactivity Parameters of a Series of Natural Diphenyl Acetone Analogues, and In Vitro Caco-2 Studies on Three Main Chalcone Derivatives

A Naturally Occurring Flavone (Chrysin): Chemistry, Occurrence, Pharmacokinetic, Toxicity, Molecular Targets and Medicinal Properties

Phloretin cytoprotection and toxicity

A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects

Chemical reactivity and biological activity of chalcones and other α,β-unsaturated carbonyl compounds

Biological Effects and Mechanisms of Dietary Chalcones: Latest Research Progress, Future Research Strategies, and Challenges

Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials

Comparative Characterization of the Metabolites of Phloretin and Phlorizin in Rats Using UHPLC-Q-Exactive Orbitrap Mass Spectrometer

Chalcone Derivatives: Role in Anticancer Therapy

Exploring Chalcone Derivatives: Synthesis and Their Therapeutic Potential

The Apple Dihydrochalcone Phloretin Suppresses Growth and Improves Chemosensitivity of Breast Cancer Cells Via Inhibition of Cytoprotective Autophagy

Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action